None listed
Conditions
Brief summary
Most children with cerebral palsy (CP) have a speech difficulty called dysarthria, which makes their speech unclear and difficult to understand. Sometimes dysarthria is so severe that the child is unable to speak at all. Dynamic Tactile Temporal Cuing (DTTC) is a motor speech intervention designed for young children with severe motor speech disorders including childhood apraxia of speech (CAS), a similar condition to dysarthria in CP. DTTC focusses on learning how to move the muscles required for speaking while learning to say words. This may be particularly suitable for children with CP and dysarthria, as CP is primarily a disorder of movement so the individual has difficulty is in moving and coordinating muscles, including the muscles used for speech. This study aims to investigate if DTTC improves speech clarity and intelligibility, leading to increased participation in conversations, and if these improvements last beyond therapy. We will also explore the perspectives of he parents/ guardians and the speech pathologists with DTTC via semi-structured interviews and a questionnaire. If the study confirms that DTTC improves speech, we will conduct a larger, externally funded study. This research aims to improve the lives of these children by enhancing their communication abilities and overall participation in daily conversations.
Interventions
Dynamic Tactile Temporal Cuing (DTTC) is a motor speech intervention designed for young children with severe motor speech disorders including childhood apraxia of speech (CAS), a similar condition to dysarthria in cerebral palsy. DTTC focuses on learning to move the muscles required for speaking while learning to say words. DTTC involves stimulation techniques of “look at me, listen to me, say what I say”. A set of 20 meaningful target words that contain sounds that the child already can produce and those sounds that are emerging are practiced in intensive drill. The speech pathologist systematically works toward independent (non-imitated) production of the words by fading cues in a cueing hierarchy. The cues include slow speaking rate, the length of time between clinician model and child’s response, and tactile cues to demonstrate articulatory configurations (the movements and placement of the tongue, cheeks, and lips). Rapid reinforcers (feedback on the correctness of the production and on how to produce the word/ phrase) are used to maximize the number of practice trials per session. Cues are individual to the child and the clinician moves along the cuing hierarchy to facilitate accurate production while moving towards independent production. DTTC intervention will be provided three times a week for six weeks by speech pathologists trained in DTTC intervention. Each session runs for one hour. The sessions will be in-person at a Cerebral Palsy Alliance site closest to the participant's home. All treating speech pathologists will undergo training for DTTC a minimum of one month before the commencement of the intervention. The following training will take place: 1. Complete DTTC online training https://childapraxiatreatment.org/dttc/. 2. Complete a three-hour training on the implementation of DTTC, delivered over two or three sessions depending on the speech pathologist’s availability. The CI or the other speech pathologists in the research team will provide the training individually to each speech pathologist or in groups of two online or in-person. A standardized DTTC intervention manual will be developed and used in the training. 3. The CI or the other speech pathologists in the team will observe the treating clinician’s first or the second treatment session with their first participant after which they will provide coaching feedback to the speech pathologist. Adherence to DTTC intervention will be monitored by the Chief Investigator (CI) and the other speech pathologists in the research team. In addition to the initial clinician observation, the CI or the other speech pathologists will also observe three more randomly selected treatment sessions to observe fidelity to the DTTC intervention. If Fidelity drops below 90%, the speech pathologist will be provided with further training and support by the Chief Investigator or other speech pathologists in the research team. The length of baselines: Following the pre-treatment assessment, children will be randomized to complete 3, 4 or 5 pre-treatment probe assessments during baseline period. Children will be randomized to one of the following conditions: - 3 pre-treatment probes: 2 x on 1 week before treatment and 1x on the first week of treatment - 4 pre-treatment probes: 1 x on 2 weeks before treatment, 2 x 1 week before treatment, 1 x 1 on the first week of treatment. - 5 pre-treatment probes: 2 x on 2 weeks before treatment, 2 x 1 week before treatment, 1 x 1 on the first week of treatment
Sponsors
Study design
Eligibility
Inclusion criteria
1. Diagnosis of CP 2. Viking Speech Scale (VSS) II-IV 3. No diagnosed intellectual disability 4. Normal or adjusted-to-normal hearing and vision 5. English as primary language
Exclusion criteria
1. Concomitant genetic or neurodevelopmental disorder 2. Oral or facial structural deficit